Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

MED BIOGENE INC V.MBI

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  MBGNF

Med BioGene Inc is a development stage life science company. The Company is engaged in the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer.
Price: $0.06 Volume: 65,000
Change: $0.00 % Change: 0.00%
Day High/Low: 0.06/0.055 52 Week High/Low: 0.125/0.03
Last Traded: March 04, 2015 10:56 Transaction Volume: 50000
Open: 0.06 Previous Close: 0.06
Bid: 0.06 Ask: 0.065
Bid Size: 16000 Ask Size: 10000
Market Cap: 5.2m Shares Out: 86.6m
PE Ratio: N/A Dividend Yield: N/A

Opinion

Is Med Biogene (V.MBI) poised for a breakout?

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   January 13, 2014
0 stars

Stockhouse Research: Habanero jumps, Blackberry drops, Fission hangs

The best of our bullboards, blogs, stories and groups for August 30, 2013.

Chris Parry   August 30, 2013
0 stars

Latest Bullboard Posts

  • RE:Thoughts

    0 stars

    As someone waiting for 4.5/5 to add, my thoughts are...shoot, hope I didn't miss it...lol. Still think we can get one more low.

    3 stars


  • RE:RE:Thoughts

    0 stars

    Helomics is launching the product into the research market this quarter and the utility data will be instrumental in shaping updates...

    3 stars


  • RE:Thoughts

    0 stars

    I think that the many weeks spent at 3-3.5 cents still has an effect on many shareholders. A lot of buyers are waiting for a lower price...

    2.5 stars


  • Thoughts

    0 stars

    Q2 is fast approaching hopefully with news. Are people waiting for WJ to show more than just intent?

    3 stars


  • RE:NR regarding new director

    0 stars

    Congratulations and welcome our new director Ms Sidhu. Very comforting to know that she like WJ is like one of us MBI long term investors...

    3 stars